Boehringer Ingelheim (Canada) Ltd.

Canada

1 July 2020 - 30 June 2021

No articles found. Boehringer Ingelheim (Canada) Ltd. did not contribute to any primary research papers from Nature Index journals in the current 12 month window.

C. H. Boehringer Sohn AG & Co. KG (Boehringer Ingelheim)

↳ Boehringer Ingelheim International GmbH

↳ Boehringer Ingelheim (Canada) Ltd.

Boehringer Ingelheim Corporation

Boehringer Ingelheim Ltd.

Boehringer Ingelheim Pharmaceuticals, Inc.

Boehringer Ingelheim RCV GmbH & Co. KG

Nippon Boehringer Ingelheim Co. Ltd.

Boehringer Ingelheim GmbH

Boehringer Ingelheim Pharma GmbH & Co. KG

Boehringer Ingelheim Vetmedica GmbH

Boehringer Ingelheim Animal Health, Inc.

Boehringer Ingelheim Vetmedica, Inc.

ViraTherapeutics GmbH

Return to institution outputs

Latest supplement

Nature Index 2021 Infectious disease

COVID-19 has brought new urgency to the study of infectious disease. This Nature Index supplement shines a light on some of the research, and the people and institutions behind it, that aims to reduce the staggering human and economic cost of communicable disease.

Access free

Research highlights of partners

Structure of cockroach protein could lead to new painkillers

The University of Queensland (UQ)

2 Apr 2019

Managing a molecular break-up

University of Tsukuba

31 Jul 2019

Gene link found between hepatitis C and diabetes

Kanazawa University (KU)

31 Oct 2019

Research highlights

Sign up for the free weekly Nature Index newsletter
Sign up